Merav D. Shmueli

Merav D. Shmueli

Auto-generated profile, based on publicly available information

Merav D. Shmueli

Department of Systems Immunology, Weizmann Institute of Science, Rehovot, Israel

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
18 March 2022 in Cell
Verified
Journal Article
Closed access
RMRoei D. Mazor
Roei D. Mazor
NNNachum Nathan
Nachum Nathan
AGAmit Gilboa
Amit Gilboa
LSLiat Stoler-Barak
Liat Stoler-Barak
LMLihee Moss
Lihee Moss
ZSZiv Shulman
Ziv Shulman

6 October 2022 in Nature Biotechnology
Verified
Journal Article
Closed access
PDF file
AKAssaf Kacen
Assaf Kacen
AJAaron Javitt
Aaron Javitt
MKMatthias P. Kramer
Matthias P. Kramer
DMDavid Morgenstern
David Morgenstern
TTTomer Tsaban
Tomer Tsaban
YMYifat Merbl
Yifat Merbl

5 March 2025 in Nature
Verified
Journal Article
Open access
PDF file
KGKarin Goldberg
Karin Goldberg
ALArseniy Lobov
Arseniy Lobov
PAPaola Antonello
Paola Antonello
MSMerav D. Shmueli
Merav D. Shmueli
IYIdan Yakir
Idan Yakir
YMYifat Merbl
Yifat Merbl
For decades, antigen presentation on major histocompatibility complex class I for T cell-mediated immunity has been considered the primary function of proteasome-derived peptides1,2. However, whether the products of proteasomal degradation play additional parts in mounting immune responses remains unknown. Antimicrobial peptides serve as a first line of defence against invading pathogens before the adaptive immune system responds. Although the protective function of antimicrobial peptides across numerous tissues is well established, the cellular mechanisms underlying their generation are not fully understood. Here we uncover a role for proteasomes in the constitutive and bacterial-induced generation of defence peptides that impede bacterial growth both in vitro and in vivo by disrupting bacterial membranes. In silico prediction of proteome-wide proteasomal cleavage identified hundreds of thousands of potential proteasome-derived defence peptides with cationic properties that may be generated en route to degradation to act as a first line of defence. Furthermore, bacterial infection induces changes in proteasome composition and function, including PSME3 recruitment and increased tryptic-like cleavage, enhancing antimicrobial activity. Beyond providing mechanistic insights into the role of proteasomes in cell-autonomous innate immunity, our study suggests that proteasome-cleaved peptides may have previously overlooked functions downstream of degradation. From a translational standpoint, identifying proteasome-derived defence peptides could provide an untapped source of natural antibiotics for biotechnological applications and therapeutic interventions in infectious diseases and immunocompromised conditions.

22 May 2023 in Nature Cancer
Verified
Journal Article
Closed access
PDF file
AJAaron Javitt
Aaron Javitt
MSMerav D. Shmueli
Merav D. Shmueli
MKMatthias P. Kramer
Matthias P. Kramer
AKAleksandra A. Kolodziejczyk
Aleksandra A. Kolodziejczyk
ICIvan J. Cohen
Ivan J. Cohen
YMYifat Merbl
Yifat Merbl

20 March 2023 in Nature Immunology
Verified
Journal Article
Closed access
PDF file
DZDanping Zheng
Danping Zheng
GMGayatree Mohapatra
Gayatree Mohapatra
LKLara Kern
Lara Kern
YHYiming He
Yiming He
MSMerav D. Shmueli
Merav D. Shmueli
Eran ElinavEran Elinav
Eran Elinav

22 June 2020 in The EMBO Journal
Verified
Journal Article
Open access
PDF file
MPMartina Pigoni
Martina Pigoni
HHHung‐En Hsia
Hung‐En Hsia
JHJana Hartmann
Jana Hartmann
JNJasenka Rudan Njavro
Jasenka Rudan Njavro
MSMerav D Shmueli
Merav D Shmueli
SLStefan F Lichtenthaler
Stefan F Lichtenthaler
Seizure protein 6 (SEZ6) is required for the development and maintenance of the nervous system, is a major substrate of the protease BACE1 and is linked to Alzheimer's disease (AD) and psychiatric disorders, but its molecular functions are not well understood. Here, we demonstrate that SEZ6 controls glycosylation and cell surface localization of kainate receptors composed of GluK2/3 subunits. Loss of SEZ6 reduced surface levels of GluK2/3 in primary neurons and reduced kainate‐evoked currents in CA1 pyramidal neurons in acute hippocampal slices. Mechanistically, loss of SEZ6 in vitro and in vivo prevented modification of GluK2/3 with the human natural killer‐1 (HNK‐1) glycan, a modulator of GluK2/3 function. SEZ6 interacted with GluK2 through its ectodomain and promoted post‐endoplasmic reticulum transport of GluK2 in the secretory pathway in heterologous cells and primary neurons. Taken together, SEZ6 acts as a new trafficking factor for GluK2/3. This novel function may help to better understand the role of SEZ6 in neurologic and psychiatric diseases.